G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19
Authorda Rocha, Jorge E B
Tiemessen, Caroline T
MetadataShow full item record
AbstractChloroquine/hydroxychloroquine have been proposed as potential treatments for COVID-19. These drugs have warning labels for use in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Analysis of whole genome sequence data of 458 individuals from sub-Saharan Africa showed significant G6PD variation across the continent. We identified nine variants, of which four are potentially deleterious to G6PD function, and one (rs1050828) that is known to cause G6PD deficiency. We supplemented data for the rs1050828 variant with genotype array data from over 11,000 Africans. Although this variant is common in Africans overall, large allele frequency differences exist between sub-populations. African sub-populations in the same country can show significant differences in allele frequency (e.g. 16.0% in Tsonga vs 0.8% in Xhosa, both in South Africa, p = 2.4 × 10-3). The high prevalence of variants in the G6PD gene found in this analysis suggests that it may be a significant interaction factor in clinical trials of chloroquine and hydroxychloroquine for treatment of COVID-19 in Africans.
Rights/Terms© 2021. The Author(s).
KeywordClinical Trials as Topic
Glucosephosphate Dehydrogenase Deficiency--genetics
Africa South of the Sahara
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16394
- <i>G6PD</i> variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
- Authors: da Rocha J, Othman H, Tiemessen CT, Botha G, Ramsay M, Masimirembwa C, Adebamowo C, Choudhury A, Brandenburg JT, Matshaba M, Simo G, Gamo FJ, Hazelhurst S
- Issue date: 2020 Jun 2
- High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
- Authors: Millimono TS, Loua KM, Rath SL, Relvas L, Bento C, Diakite M, Jarvis M, Daries N, Ribeiro LM, Manco L, Kaeda JS
- Issue date: 2012
- The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.
- Authors: Capoluongo ED, Amato F, Castaldo G
- Issue date: 2020 Jun 25
- No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency.
- Authors: Schilling WHK, Bancone G, White NJ
- Issue date: 2020 Nov
- Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.
- Authors: Barišić M, Korać J, Pavlinac I, Krželj V, Marušić E, Vulliamy T, Terzić J
- Issue date: 2005